Signal Pharmaceuticals
Acquired- Headquarters
- San Diego, California
- Business Model
- B2B
- Last Round
- Series AJan 1994
- Rounds
- 2
About
Signal Pharmaceuticals was a San Diego, California-based biotechnology company focused on discovering new classes of drugs that regulate genes associated with disease through signal transduction research. Co-founded by UCSD researcher Michael Karin, the company pursued a novel approach to drug discovery based on the regulation of gene expression — targeting signaling pathways that control disease-related genes rather than the genes themselves. Signal Pharmaceuticals conducted research into IkB Kinase (IKK) and related inflammatory pathway targets relevant to cancer and immune disorders. The company was acquired by Celgene Corporation and rebranded as Celgene Research San Diego.
Summary
Signal Pharmaceuticals is a Biotech company based in San Diego, United States. Its most recent funding was a Series A round in Jan 1994. Investors include Accel and Venrock.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2000
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.